Repligen | RGEN - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
Agilent USD 25M 2M 2025-12
Align Technology USD 16.04M 14.04M 2025-12
Bio Techne USD 2.18M 173K 2025-06
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Bristol-Myers Squibb USD 411M 21M 2026-03
Bruker USD 20M 4.3M 2025-09
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
General Electric Aerospace USD 496M 271M 2025-12
Henry Schein USD 39M 0 2026-03
Illumina USD 26M 1000K 2025-12
IQVIA Holdings USD 192M 1000K 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 671M 40M 2026-03
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 42M 33.38M 2026-03
West Pharmaceutical Services USD 1.9M 1.7M 2026-03